| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Another year
|
Cavalli, F.
|
|
|
9 |
1 |
p. 7
|
article
|
| 2 |
Another year
|
F. Cavalli
|
|
1998
|
9 |
1 |
p. 7-7
1 p.
|
article
|
| 3 |
A phase I and pharmacologic study of DMP 840 administered by 24-hour infusion* * Presented in part at the 31st Annual Meeting of the American Society of Clinical Oncology, Los Angeles, CA, USA, 20–23 May 1995.
|
O’Reilly, S.
|
|
|
9 |
1 |
p. 101-104
|
article
|
| 4 |
A phase I trial of human corticotropin-releasing factor (hCRF) in patients with peritumoral brain edema
|
Villalona-Calero, M.A.
|
|
|
9 |
1 |
p. 71-77
|
article
|
| 5 |
A phase I trial of human corticotropin-releasing factor (hCRF) inpatients with peritumoral brain edema
|
M. A. Villalona-Calero
|
|
1998
|
9 |
1 |
p. 71-77
7 p.
|
article
|
| 6 |
Awards, appointments
|
|
|
|
9 |
1 |
p. 5
|
article
|
| 7 |
Blood stem cell transplantation. Cancer treatment andresearch. J.N. Winter (ed).
|
M. Ghielmini
|
|
1998
|
9 |
1 |
p. 8-8
1 p.
|
article
|
| 8 |
Book review
|
Neuenschwander, H.
|
|
|
9 |
1 |
p. 120
|
article
|
| 9 |
Book review
|
Ghielmini, M.
|
|
|
9 |
1 |
p. 8
|
article
|
| 10 |
Carboplatin versus cisplatin in solid tumors: An analysis of the literature
|
Lokich, J.
|
|
|
9 |
1 |
p. 13-21
|
article
|
| 11 |
Carboplatin versus cisplatin in solid tumors: An analysis of theliterature
|
J. Lokich
|
|
1998
|
9 |
1 |
p. 13-21
9 p.
|
article
|
| 12 |
CD44v6 is not a prognostic factor in primary breast cancer
|
Jansen, R.H.L.
|
|
|
9 |
1 |
p. 109-111
|
article
|
| 13 |
CD44v6 is not a prognostic factor in primary breast cancer
|
R. H. L. Jansen
|
|
1998
|
9 |
1 |
p. 109-111
3 p.
|
article
|
| 14 |
Consensus conference on high-dose therapy with hematopoietic stem celltransplantation in diffuse large-cell lymphoma
|
A. Kessinger
|
|
1998
|
9 |
1 |
p. 23-30
8 p.
|
article
|
| 15 |
Contents of the next issue
|
|
|
|
9 |
1 |
p. vii
|
article
|
| 16 |
Contents of the next issue
|
|
|
1998
|
9 |
1 |
p. 0-0
1 p.
|
article
|
| 17 |
Copyright
|
|
|
|
9 |
1 |
p. v
|
article
|
| 18 |
Detection of chromosome 3p alterations in serum DNA of non-small-cell lung cancer patients
|
Sánchez-Céspedes, M.
|
|
|
9 |
1 |
p. 113-116
|
article
|
| 19 |
Detection of chromosome 3p alterations in serum DNA of non-small-celllung cancer patients
|
M. Sánchez-Céspedes
|
|
1998
|
9 |
1 |
p. 113-116
4 p.
|
article
|
| 20 |
Editorial board
|
|
|
|
9 |
1 |
p. vi
|
article
|
| 21 |
Efficacy and safety of the paclitaxel and carboplatin combination in patients with previously treated advanced ovarian carcinoma
|
Guastalla, J.P.
|
|
|
9 |
1 |
p. 37-43
|
article
|
| 22 |
Equianalgesic dose/ratio between methadone and other opioid agonists in cancer pain: Comparison of two clinical experiences
|
Ripamonti, C.
|
|
|
9 |
1 |
p. 79-83
|
article
|
| 23 |
Equianalgesic dose/ratio between methadone and other opioid agonists incancer pain: Comparison of two clinical experiences
|
C. Ripamonti
|
|
1998
|
9 |
1 |
p. 79-83
5 p.
|
article
|
| 24 |
Ethics in Hospice care: Challenges to Hospice valuesin a changing health care environment. B. Jennings (ed).
|
H. Neuenschwander
|
|
1998
|
9 |
1 |
p. 120-120
1 p.
|
article
|
| 25 |
Freys syndrome after cisplatin-based chemotherapy for testicularteratoma
|
P. Beale
|
|
1998
|
9 |
1 |
p. 118-119
2 p.
|
article
|
| 26 |
Frey’s syndrome after cisplatin-based chemotherapy for testicular teratoma
|
Beale, P.
|
|
|
9 |
1 |
p. 118-119
|
article
|
| 27 |
G-CSF prevents the suppression of bone marrow hematopoiesis induced by IL-12 and augments its antitumor activity in a melanoma model in mice
|
Gołąb, I.
|
|
|
9 |
1 |
p. 63-69
|
article
|
| 28 |
G-Csf prevents the suppression of bone marrow hematopoiesis induced byIL-12 and augments its antitumor activity in a melanoma model in mice
|
J. Gob
|
|
1998
|
9 |
1 |
p. 63-69
7 p.
|
article
|
| 29 |
German oncology research shaken by fraud case
|
Abbott, Alison
|
|
|
9 |
1 |
p. 1-2
|
article
|
| 30 |
German oncology research shaken by fraud case; Hemato-oncologists meetagain at Airlie House; Hemato-oncology refashioned in the NeueBundesländer; Awards, appointments; Perhaps not everyone knows that...;Climate change
|
|
|
1998
|
9 |
1 |
p. 1-6
6 p.
|
article
|
| 31 |
Hemato-oncologists meet again at Airlie House
|
|
|
|
9 |
1 |
p. 2-4
|
article
|
| 32 |
Hemato-oncology refashioned in the ‘Neue Bundesländer’
|
|
|
|
9 |
1 |
p. 4-5
|
article
|
| 33 |
High-dose chemotherapy and hematopoietic stem cell transplantation forrelapsed or refractory diffuse large-cell non-Hodgkins lymphoma
|
J. M. Vose
|
|
1998
|
9 |
1 |
p. 1-3
3 p.
|
article
|
| 34 |
High-dose therapy followed by stem cell transplantation in partialresponse after first-line induction therapy for aggressive non-Hodgkinslymphoma
|
C. Haioun
|
|
1998
|
9 |
1 |
p. 5-8
4 p.
|
article
|
| 35 |
High-dose therapy for diffuse large-cell lymphoma in firstremission
|
A. R. Perry
|
|
1998
|
9 |
1 |
p. 9-14
6 p.
|
article
|
| 36 |
Immunotherapy in conjunction with autologous and allogeneic blood ormarrow transplantation in lymphoma
|
S. Slavin
|
|
1998
|
9 |
1 |
p. 31-39
9 p.
|
article
|
| 37 |
Incidence, mortality and survival from prostate cancer in Vaud and Neuchâtel, Switzerland, 1974–1994
|
Levi, F.
|
|
|
9 |
1 |
p. 31-35
|
article
|
| 38 |
Incidence, mortality and survival from prostate cancer in Vaud andNeuchâtel, Switzerland, 19741994
|
F. Levi
|
|
1998
|
9 |
1 |
p. 31-35
5 p.
|
article
|
| 39 |
Instructions to authors
|
|
|
|
9 |
1 |
p. 121-122
|
article
|
| 40 |
In this Issue
|
|
|
|
9 |
1 |
p. vii
|
article
|
| 41 |
In this issue
|
|
|
1998
|
9 |
1 |
p. 0-0
1 p.
|
article
|
| 42 |
Management of an isolated thymic mass after primary therapy for lymphoma
|
Anchisi, S.
|
|
|
9 |
1 |
p. 95-100
|
article
|
| 43 |
Management of an isolated thymic mass after primary therapy forlymphoma
|
S. Anchisi
|
|
1998
|
9 |
1 |
p. 95-100
6 p.
|
article
|
| 44 |
No evidence of significant activity of the multidrug resistance gene product in primary human breast cancer
|
Hegewisch-Becker, S.
|
|
|
9 |
1 |
p. 85-93
|
article
|
| 45 |
No evidence of significant activity of the multidrug resistance geneproduct in primary human breast cancer
|
S. Hegewisch-Becker
|
|
1998
|
9 |
1 |
p. 85-93
9 p.
|
article
|
| 46 |
Oxaliplatin as single agent in previously untreated colorectal carcinoma patients: A phase II multicentric study
|
Díaz-Rubio, E.
|
|
|
9 |
1 |
p. 105-108
|
article
|
| 47 |
Oxaliplatin as single agent in previously untreated colorectal carcinomapatients: A phase II multicentric study
|
E. Díaz-Rubio
|
|
1998
|
9 |
1 |
p. 105-108
4 p.
|
article
|
| 48 |
Paclitaxel in combination with weekly 24-hour infusional 5-fluorouracil plus leucovorin in the second-line treatment of metastatic breast cancer: Results of a phase II study
|
Klaassen, U.
|
|
|
9 |
1 |
p. 45-50
|
article
|
| 49 |
Paclitaxel in combination with weekly 24-hour infusional 5-fluorouracilplus leucovorin in the second-line treatment of metastatic breast cancer:Results of a phase II study
|
U. Klaassen
|
|
1998
|
9 |
1 |
p. 45-50
6 p.
|
article
|
| 50 |
Perhaps not everyone knows that…
|
|
|
|
9 |
1 |
p. 5-6
|
article
|
| 51 |
Prevention of hepatitis development by interferon-alpha in HBV carriers treated with intensive chemotherapy: A pilot study
|
Kumagai, K.
|
|
|
9 |
1 |
p. 117-118
|
article
|
| 52 |
Prevention of hepatitis development by interferon-alpha in HBV carrierstreated with intensive chemotherapy: A pilot study
|
K. Kumagai
|
|
1998
|
9 |
1 |
p. 117-118
2 p.
|
article
|
| 53 |
Prostate cancer: Screening or watchful waiting?
|
Weyler, J.
|
|
|
9 |
1 |
p. 9-11
|
article
|
| 54 |
Prostate cancer: Screening or watchful waiting?
|
J. Weyler
|
|
1998
|
9 |
1 |
p. 9-11
3 p.
|
article
|
| 55 |
Rearrangements of bcl-6, bcl-2, c-myc and 6q deletion in B-diffuselarge-cell lymphoma: Clinical relevance in 71 patients
|
U. Vitolo
|
|
1998
|
9 |
1 |
p. 55-61
7 p.
|
article
|
| 56 |
Rearrangements of bcl-6, bcl-2, c-myc and 6q deletion in B-diffuse large-cell lymphoma: Clinical relevance in 71 patients
|
Vitolo, U.
|
|
|
9 |
1 |
p. 55-61
|
article
|
| 57 |
Recent advances in the molecular genetics of cancer
|
Spataro, V.
|
|
|
9 |
1 |
p. 23-29
|
article
|
| 58 |
Selection and immunomagnetic purging of peripheral blood CD34+ cells for autologous transplantation in B-cell non-Hodgkin’s lymphomas
|
Pichert, G.
|
|
|
9 |
1 |
p. 51-54
|
article
|
| 59 |
Suggested questions for the jury
|
M. A. Shipp
|
|
1998
|
9 |
1 |
p. 47-47
1 p.
|
article
|
| 60 |
Table of Contents
|
|
|
|
9 |
1 |
p. iv-v
|
article
|
| 61 |
Title Page
|
|
|
|
9 |
1 |
p. iii
|
article
|
| 62 |
Tumor vaccination strategies combined with autologous peripheral stemcell transplantation
|
L. W. Kwak
|
|
1998
|
9 |
1 |
p. 41-46
6 p.
|
article
|
Journal description